Foster City, CA, United States of America

Chia-Ying Kao Lam

This inventor holds 12 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Macrogenics, Inc., Duke University, The University of North Carolina at Chapel Hill. Active years: 2018-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chia-Ying Kao Lam. Retrieved from https://idiyas.com/inventor/chia-ying-kao-lam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 8)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 6)

EPO Patents = 3 (Patent Applications = 10)

Average Co-Inventor Count = 7.2

ph-index = 2

Forward Citations = 19(Granted Patents)

Location History:

Foster City, CA (US) (2018 - 2022)
San Jose, CA (US) (2020 - 2023)
Rockville, MD (US) (2023 - 2024)

Company Filing History:

The University of North Carolina at Chapel Hill

patents

4. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2018-2024

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12173051 - Bispecific molecules comprising an HIV-1 envelope targeting arm (2024-12-24),

2. 11942149 - Bispecific binding molecules that are capable of binding CD137 and tumor antigens, and uses thereof (2024-03-26),

3. 11820818 - Multi-chain polypeptide-containing tri-specific binding molecules (2023-11-21),

4. 11685781 - Variant CD3-binding domains and their use in combination therapies for the treatment of disease (2023-06-27),

5. 11639386 - Bi-specific monovalent diabodies that are capable of binding CD19 and CD3, and uses thereof (2023-05-02),

6. 11459394 - Bispecific binding molecules that are capable of binding CD137 and tumor antigens, and uses thereof (2022-10-04),

7. 11421031 - Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof (2022-08-23),

8. 10730947 - Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof (2020-08-04),

9. 10717778 - Bispecific molecules comprising an HIV-1 envelope targeting arm (2020-07-21),

10. 10647768 - Multi-chain polypeptide-containing tri-specific binding molecules (2020-05-12),

11. 10633443 - Bi-specific monovalent diabodies that are capable of binding CD19 and CD3, and uses thereof (2020-04-28),

12. 9908938 - Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof (2018-03-06),

Title: The Innovative Journey of Chia-Ying Kao Lam

Introduction: Chia-Ying Kao Lam, a visionary inventor based in Foster City, CA (US), has made significant contributions to the field of technology with his groundbreaking inventions.

Latest Patents: Chia-Ying Kao Lam holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovative spirit.

Career Highlights: With a background in engineering and a passion for creating solutions to complex problems, Chia-Ying Kao Lam has led successful projects that have revolutionized industries and improved the lives of many.

Collaborations: Throughout his career, Chia-Ying Kao Lam has collaborated with top research institutions, leading companies, and brilliant minds in the field, fostering a culture of innovation and excellence.

Conclusion: Chia-Ying Kao Lam's relentless pursuit of innovation and his commitment to pushing the boundaries of what is possible make him a true pioneer in the world of inventions. His impact will continue to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.